Talis Biomedical Corporation Operating Lease, Payments
Talis Biomedical Corporation reported Operating Lease, Payments of $3.96 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Cash Flow
us-gaap:OperatingLeasePayments · last filed 2024-03-28
- Talis Biomedical Corporation operating lease, payments for the quarter ending 2022-12-31 was $406.00K, a 37.63% increase year-over-year.
- Talis Biomedical Corporation operating lease, payments for the quarter ending 2022-09-30 was $343.00K, a 18.69% increase year-over-year.
- Talis Biomedical Corporation operating lease, payments for the quarter ending 2022-06-30 was $322.00K, a 23.37% increase year-over-year.
- Talis Biomedical Corporation operating lease, payments for the quarter ending 2021-12-31 was $295.00K.
- Talis Biomedical Corporation operating lease, payments for fiscal 2023 was $3.96M, a 191.54% increase from fiscal 2022.
- Talis Biomedical Corporation operating lease, payments for fiscal 2022 was $1.36M, a 29.52% increase from fiscal 2021.
- Talis Biomedical Corporation operating lease, payments for fiscal 2021 was $1.05M, a 29.47% increase from fiscal 2020.
- Talis Biomedical Corporation operating lease, payments for fiscal 2020 was $811.00K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2023-12-31 | $3.96M 10-K · filed 2024-03-28 | |||
| 2022-12-31 | $406.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $749.00K derived: sum of 2 quarters · filed 2024-03-28 | $1.07M derived: sum of 3 quarters · filed 2024-03-28 | $1.36M 10-K · filed 2024-03-28 |
| 2022-09-30 | $343.00K 10-Q · filed 2022-11-03 | $665.00K derived: sum of 2 quarters · filed 2022-11-03 | $954.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $322.00K 10-Q · filed 2022-08-02 | $611.00K 10-Q · filed 2022-08-02 | ||
| 2021-12-31 | $295.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $584.00K derived: sum of 2 quarters · filed 2023-03-22 | $845.00K derived: sum of 3 quarters · filed 2023-03-22 | $1.05M 10-K · filed 2023-03-22 |
| 2021-09-30 | $289.00K 10-Q · filed 2022-11-03 | $550.00K derived: sum of 2 quarters · filed 2022-11-03 | $755.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $261.00K 10-Q · filed 2022-08-02 | $466.00K 10-Q · filed 2022-08-02 | ||
| 2020-12-31 | $811.00K 10-K · filed 2022-03-15 |